CVS Health (CVS) Tops Q2 EPS by 75c; raises guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $94.72 +1.30%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.58, $0.75 better than the analyst estimate of $1.83. Revenue for the quarter came in at $106.1 billion versus the consensus estimate of $100.03 billion.
GUIDANCE:
CVS Health sees FY2026 EPS of $7.90-$8.10, versus the consensus of $7.45.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Lulu’s Fashion Lounge Holdings (LVLU) Misses Q2 EPS by 37c
- CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
